CYSTOREWINE SOLUTION FOR ORAL INJECTION (Each 100ml contains Gonadoretion 0.005g)
Gonadoretion 0.005g
What it does
Gonadorelin is a hormone used to treat certain conditions related to hormone levels in the body.
Commonly used for: delayed puberty, infertility, hypogonadism
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Food and Drugs Authority · fetched 2026-07-10 04:00:16 · updated 2026-10-20 04:00:12
About this medicine
Gonadorelin is a hormone used to treat certain conditions related to hormone levels in the body.
What it treats
- delayed puberty
- infertility
- hypogonadism
How it works
Gonadorelin stimulates the release of hormones that help regulate reproductive functions.
Who it's for
This medication is for people with specific hormonal disorders, usually diagnosed by a healthcare provider.
Cautions
- • Consult a doctor if you have a history of hormone-related cancers
- • Inform your doctor about any other medications you are taking
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: gonadoretion
Gonadorelin, commonly referred to as gonadoretion, is a synthetic analog of gonadotropin-releasing hormone (GnRH). It plays a crucial role in the regulation of reproductive hormones and is used primarily in the treatment of conditions related to reproductive health. By stimulating the pituitary gland, it promotes the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are essential for the normal functioning of the reproductive system.
Indications
- Hypogonadism
- Infertility in both males and females
- Assessment of pituitary function
- Treatment of certain types of precocious puberty
Dosage
Children: Refer to specific pediatric dosing guidelines and recommendations for appropriate administration based on age and condition.
Adults: Refer to specific prescribing information for adult dosing as it may vary based on the clinical indication and patient response.
Mechanism of action
Gonadorelin acts on the GnRH receptors in the pituitary gland, initiating a cascade that leads to the secretion of LH and FSH. These gonadotropins then stimulate the gonads to produce sex steroids, such as estrogen and testosterone, thereby regulating various reproductive functions. The pulsatile release of gonadorelin is critical for maintaining normal reproductive hormone levels.
Pharmacodynamics
Gonadorelin influences the hypothalamic-pituitary-gonadal (HPG) axis, mediating the release of gonadotropins. Its pharmacodynamics are characterized by a dose-dependent response, where low-frequency administration mimics the natural pulsatile release of GnRH, effectively stimulating gonadotropin release, while continuous administration can lead to downregulation of GnRH receptors and suppression of gonadotropin secretion.
Pharmacokinetics
Gonadorelin is typically administered via subcutaneous or intravenous routes. It has a short half-life, necessitating frequent dosing or continuous infusion for effective treatment. The drug is rapidly metabolized and eliminated, with renal clearance playing a significant role in its pharmacokinetics. The onset of action is relatively quick, with effects observed shortly after administration.
Contra-indications
- Hypersensitivity to gonadorelin or any of its components
- Pregnancy
- Breastfeeding
Adverse effects
- Headache
- Nausea
- Flushing
- Injection site reactions
- Ovarian hyperstimulation syndrome (OHSS)
- Changes in libido
Interactions
- May interact with other medications affecting hormonal levels
- Caution should be used when administered with other gonadotropins
Precautions
- Use with caution in patients with a history of hormone-sensitive cancers
- Careful monitoring is recommended in patients with ovarian cysts
- Patients should be informed about potential side effects and the risk of OHSS
Pregnancy
Gonadorelin is contraindicated in pregnancy due to potential risks to the fetus.
Breast-feeding
Gonadorelin is not recommended during breastfeeding as it may affect milk production.
Storage
Store in a cool, dry place, protected from light. Once reconstituted, it should be used immediately or stored as per specific product guidelines.
Formulations
- Injectable solution
- Lyophilized powder for reconstitution
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.